Humana Inc (NYSE:HUM) Shares Bought by Rhenman & Partners Asset Management AB

Rhenman & Partners Asset Management AB grew its position in Humana Inc (NYSE:HUM) by 36.4% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 105,000 shares of the insurance provider’s stock after buying an additional 28,000 shares during the period. Humana accounts for approximately 3.1% of Rhenman & Partners Asset Management AB’s investment portfolio, making the stock its 2nd largest holding. Rhenman & Partners Asset Management AB owned approximately 0.08% of Humana worth $27,857,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. BlackRock Inc. increased its stake in shares of Humana by 1.6% in the 1st quarter. BlackRock Inc. now owns 12,190,049 shares of the insurance provider’s stock valued at $3,242,553,000 after buying an additional 186,997 shares during the period. Janus Henderson Group PLC grew its stake in shares of Humana by 3.5% during the first quarter. Janus Henderson Group PLC now owns 3,596,204 shares of the insurance provider’s stock worth $956,594,000 after purchasing an additional 120,905 shares during the period. Geode Capital Management LLC grew its stake in shares of Humana by 8.3% during the fourth quarter. Geode Capital Management LLC now owns 1,773,576 shares of the insurance provider’s stock worth $507,198,000 after purchasing an additional 135,776 shares during the period. Northern Trust Corp grew its stake in shares of Humana by 0.5% during the first quarter. Northern Trust Corp now owns 1,743,519 shares of the insurance provider’s stock worth $463,775,000 after purchasing an additional 8,221 shares during the period. Finally, Wells Fargo & Company MN grew its stake in shares of Humana by 5.3% during the first quarter. Wells Fargo & Company MN now owns 1,343,162 shares of the insurance provider’s stock worth $357,281,000 after purchasing an additional 67,761 shares during the period. 92.49% of the stock is owned by institutional investors.

A number of equities research analysts recently commented on HUM shares. Citigroup decreased their price objective on Humana from $362.00 to $302.00 and set a “buy” rating for the company in a research note on Thursday, May 2nd. Zacks Investment Research cut Humana from a “hold” rating to a “sell” rating in a research note on Thursday, April 11th. Piper Jaffray Companies lifted their price objective on Humana from $315.00 to $341.00 and gave the stock an “overweight” rating in a research note on Thursday. Morgan Stanley decreased their price objective on Humana from $331.00 to $315.00 and set an “overweight” rating for the company in a research note on Friday, July 12th. Finally, ValuEngine raised Humana from a “sell” rating to a “hold” rating in a research note on Friday, July 12th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $341.21.

NYSE:HUM traded down $2.32 on Friday, reaching $295.87. The company’s stock had a trading volume of 624,221 shares, compared to its average volume of 952,245. Humana Inc has a 1-year low of $225.65 and a 1-year high of $355.88. The company has a current ratio of 1.65, a quick ratio of 1.65 and a debt-to-equity ratio of 0.40. The stock has a market cap of $38.42 billion, a price-to-earnings ratio of 20.33, a PEG ratio of 1.24 and a beta of 0.87. The stock’s 50-day moving average price is $271.36.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, July 31st. The insurance provider reported $6.05 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.24 by $0.81. The firm had revenue of $16.25 billion during the quarter, compared to analysts’ expectations of $15.88 billion. Humana had a return on equity of 20.77% and a net margin of 2.99%. The company’s revenue was up 13.9% on a year-over-year basis. During the same period in the previous year, the firm earned $3.96 earnings per share. As a group, equities research analysts forecast that Humana Inc will post 17.6 earnings per share for the current fiscal year.

About Humana

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Featured Article: Hedge Funds – Risk or Reward?

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.